https://doi.org/10.4081/reumatismo.2024.1641
Adult ocular adnexal xanthogranulomatous disease associated with immunoglobulin G4-related disease: an unusual association
Submitted: 29 August 2023
Accepted: 5 December 2023
Published: 22 March 2024
Accepted: 5 December 2023
Abstract Views: 992
PDF: 207
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Adult-onset xanthogranuloma (AOX) and immunoglobulin G4-related disease (IgG4-RD) are uncommon fibrosing conditions that may exhibit localized ocular manifestations and occasionally systemic symptoms. These conditions exhibit overlapping clinical and histological features, suggesting a potential correlation between them, although their exact relationship remains unclear. This paper presents the case of a black male patient exhibiting typical histological indications of both AOX and IgG4-RD. The patient responded positively to corticosteroid treatment.
Kerstetter J, Wang J. Adult orbital xanthogranulomatous disease. Dermatol Clin 2015; 33: 457-63.
DOI: https://doi.org/10.1016/j.det.2015.03.010
Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019; 78: 406-12
DOI: https://doi.org/10.1136/annrheumdis-2018-214603
Burris CKH, Rodriguez ME, Raven ML, Burkat CN, Albert DM. Adult-onset asthma and periocular xanthogranulomas associated with systemic IgG4-related disease. Am J Ophthalmol Case Rep 2016; 1: 34-7.
DOI: https://doi.org/10.1016/j.ajoc.2016.03.006
London J, Martin A, Soussan M, Badelon I, Gille T, Uzunhan Y, et al. Adult-onset asthma and periocular xanthogranuloma (AAPOX), a rare entity with a strong link to IgG4-related disease. Medicine 2015; 94: e1916.
DOI: https://doi.org/10.1097/MD.0000000000001916
Singh K, Rajan K, Eberhart C. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease. Ocul Immunol Inflamm 2010; 18: 373-8.
DOI: https://doi.org/10.3109/09273948.2010.490629
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 2020; 72: 7-19.
DOI: https://doi.org/10.1002/art.41120
Andron AA, Nair AG, Della Rocca D, Della Rocca RC, Reddy HS. Concomitant adult onset xanthogranuloma and IgG4-related orbital disease: a rare occurrence. Orbit 2022; 41: 108-11.
DOI: https://doi.org/10.1080/01676830.2020.1814353
Asproudis I, Kanari M, Ntountas I, Ragos V, Goussia A, Batistatou A, et al. Successful treatment with rituximab of IgG4-related disease coexisting with adult-onset asthma and periocular xanthogranuloma. Rheumatol Int 2020; 40: 671-7.
DOI: https://doi.org/10.1007/s00296-019-04409-2
Leung KCP, Ko P, Ho CHJ, Ko TCS. Adult onset xanthogranuloma associated with IgG4-related disease. Korean J Ophthalmol 2018; 32: 424-5.
DOI: https://doi.org/10.3341/kjo.2017.0145
McKelvie P, McNab AA, Hardy T, Rathi V. Comparative study of clinical, pathological, radiological, and genetic features of patients with adult ocular adnexal xanthogranulomatous disease, Erdheim-Chester disease, and IgG4-related disease of the orbit/ocular adnexa. Ophthalmic Plast Reconstr Surg 2017; 33: 112-9.
DOI: https://doi.org/10.1097/IOP.0000000000000661
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366: 539-51.
DOI: https://doi.org/10.1056/NEJMra1104650
Pomponio G, Olivari D, Mattioli M, Angeletti A, Rossetti G, Goteri G, et al. Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease. Medicine 2018; 97: e11143.
DOI: https://doi.org/10.1097/MD.0000000000011143
Ortiz Salvador JM, Subiabre Ferrer D, Pérez Ferriols A. Adult Xanthogranulomatous Disease of the Orbit: Clinical Presentations, Evaluation, and Management. Actas Dermosifiliogr 2017; 108: 400-6.
DOI: https://doi.org/10.1016/j.adengl.2017.03.030
How to Cite
de Santana, A., Castro de Oliveira Figueirôa, M., Souza Pedreira, A., Behrens Pinto, G., & Santiago, M. (2024). Adult ocular adnexal xanthogranulomatous disease associated with immunoglobulin G4-related disease: an unusual association. Reumatismo, 76(1). https://doi.org/10.4081/reumatismo.2024.1641
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- A. Colangelo, F. Tromby, G. Cafaro, R. Gerli, E. Bartoloni, C. Perricone, Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint , Reumatismo: Vol. 75 No. 3 (2023)
- G. Adami, S. Zanon, A. Fassio, G. Pesarini, M. Pighi, R. Scarsini, D. Tavella, M. Rossini, D. Gatti, F. Ribichini, Diffuse idiopathic skeletal hyperostosis is associated with greater complexity of coronary artery disease burden on coronary angiography , Reumatismo: Early Access
- A.M. Elsaman, A. Sayed, A.R. Radwan, Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study , Reumatismo: Vol. 72 No. 3 (2020)
- C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone, Inflammatory bowel diseases and spondyloarthritis: a focus on female patients , Reumatismo: Vol. 76 No. 3 (2024)
- S. Tanwar, B. Mattoo, U. Kumar, R. Dada, R. Bhatia, Does human serotonin-1A receptor polymorphism (rs6295) code for pain and associated symptoms in fibromyalgia syndrome? , Reumatismo: Vol. 73 No. 1 (2021)
- V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe, Efficacy of a gluten-free diet in reducing the widespread pain index and symptom severity scale in patients affected by fibromyalgia , Reumatismo: Vol. 75 No. 3 (2023)
- G. Adami, A. Giollo, A. Fassio, C. Benini, E. Bertoldo, F. Bertoldo, G. Orsolini, L. Idolazzi, O. Viapiana, S. Giannini, G. Passeri, E. Tacconelli, C. Micheletto, D. Gatti, M. Rossini, Vitamin D and disease severity in coronavirus disease 19 (COVID-19) , Reumatismo: Vol. 72 No. 4 (2020)
- D.C. Fernández Ávila, M. Diehl, A.M. Degrave, M. Buttazzoni, T. Pereira, M.A. Aguirre, A.L. Basquiera, M. Scolnik, Voriconazole-induced periostitis , Reumatismo: Vol. 73 No. 1 (2021)
- B. Auvinet, D. Chaleil, Identification of subgroups among fibromyalgia patients , Reumatismo: Vol. 64 No. 4 (2012)
- F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano, Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study , Reumatismo: Vol. 72 No. 1 (2020)
<< < 16 17 18 19 20 21 22 23 24 25 > >>
You may also start an advanced similarity search for this article.
